1.Bernstein G, Oppenheimer JH: Factors influencing the concentration of free and total thyroxine in patients with nonthyroidal disease. J Clin Endocrinol Metab 26:195, 1966.

1a.Silva JE, Larsen PR: Potential of brown adipose tissue type II thyroxine 5’-deiodinase as a local and systemic source of triiodothyronine in rats. J Clin Invest 76:2296-,1985.

1b.Hackney AC, Feith S, Pozos R, Seale J: Effects of high altitude and cold exposure on resting thyroid hormone concentrations. Aviat Space Environ Med 66:325-9,1995.

1c.Hackney AC, Hogdon JA, Hesslink R Jr, Trygg K: Thyroid hormone responses to military winter exercise in the Arctic region. Arctic Med Res 54:82-90,1995.

2.Wilber JF, Baum D: Elevation of plasma TSH during surgical hypothermia. J Clin Endocrinol Metab 31:372-375, 1970.

3.Fisher DA, Odell WD: Acute release of thyrotropin in the newborn. J Clin Invest 48:1670, 1969.

4.Fisher DA, Oddie TH: Neonatal thyroidal hyperactivity. Response to cooling. Am J Dis Child 107:574, 1964.

5.Hershman JM, Read DG, Bailey AL, Norman VD, Gibson TB: Effect of cold exposure on serum thyrotropin. J Clin Endocrinol Metab 30:430, 1970.

6.Nagata H, Izumiyama T, Kamata K, et al: An increase of plasma triiodothyronine concentration in man in a cold environment. J Clin Endocrinol Metab 43:1153, 1976.

7.Golstein-Golaire J, Van Haelst L, Bruno OD, Leclercq R, Copinschi G: Acute effects of cold on blood levels of growth hormone, cortisol, and thyrotropin in man. J Appl Physiol 29:622, 1970.

7a.Reed HL: Environmental Influences on thyroid hormone regulation. pp259-265 in Werner and Ingbar’s The Thyroid , Seventh Edition Braverman LE, Utiger RD eds. JB Lippincot Philadelphia 1996.

7b.McCormack PD, Reed HL, Thomas JR, Malik MJ: Increase in rT3 levels observed during extended Alaskan field operations of Naval personnel. Alaska Med 38:89-97,1996.

7c. Van Do N, Mino L., Merriam G, LeMAr H, Case HS, Palinkas LA, Reedy K, Reed HL: Elevation in serum thyroglbulin during prolonged Antarctic residence: Effect of thyroxine supplement in the polar 3,5,3’-triidothyronine syndrome. J Clin Endocrinol Metab 89:1529-1533,2004

7dReed HL, Silverman ED, Shakir KM et al: Changes in serum triodothyronine (T3) kinetics after prolonged antarctic residence: the polar T3 syndrome. J Clin Endocrinol Metab 70:965-,1990

8.Balsam A, Sexton FC: Increased metabolism of iodothyronines in the rat after short-term cold adaptation. Endocrinology 97:385, 1975.

9.Bernal J, Escobar del Rey F: Effect of the exposure to cold on the extrathyroidal conversion of L-thyroxine to triiodo-L-thyronine, and on intramitochondrial -glycerophosphate dehydrogenase activity in thyroidectomized rats on L-thyroxine. Acta Endocrinol 78:481, 1975.

9a.Tsukahara F, Uchida Y, Ohba K, Nomoto T, Muraki T: Defective stimulation of thyroxine 5’-deiodinase activity by cold exposure and norepinephrine in brown adipose tissue of monosodium glutamate-obese mice. Horm Metab Res 29:496-500,1997.

9b. Margarity M, Valcana T Effect of cold exposure on thyroid hormone metabolism and nuclear bindng in rat brain. Neurochem Res 24:423-6, 1999

10.DuRuisseau JP: Seasonal variation of PBI in healthy Montrealers. J Clin Endocrinol Metab 25:1513, 1965.

11.Smals AGH, Ross HA, Kloppenborg PWC: Seasonal variation in serum T3 and T4 levels in man. J Clin Endocrinol Metab 44:998, 1977.

12.Panda JN, Turner CW: Effect of thyroidectomy and low environmental temperature (4.4C) upon plasma and pituitary thyrotrophin in the rat. Acta Endocrinol 54:485, 1975.

13.Emerson CH, Utiger RD: Plasma thyrotropin-releasing hormone concentrations in the rat. J Clin Invest 56:1564, 1975.

14.Andersson B: Hypothalamic temperature and thyroid action. C. F. S. G. 18 (eds), Brain-THyroid Relationships, pp. 35-50,1964.

15.Montoya E, Seibel MJ, Wilber JF: Thyrotropin-releasing hormone secretory physiology: studies by radioimmunoassay and affinity chromatography. Endocrinology 96:1413, 1975.

16.Szabo M, Frohman LA: Suppression of cold-stimulated thyrotropin secretion by antiserum to thyrotropin-releasing hormone. Endocrinology 101:1023, 1977.

17.Hefco E, Krulich L, Illner P, Larsen PR: Effect of acute exposure to cold on the activity of the hypothalamic-pituitary-thyroid system. Endocrinology 97:1185, 1975.

18.Jobin M, Ferland L, Coté J, Labrie F: Effect of exposure to cold on hypothalamic TRH activity and plasma levels of TSH and prolactin in the rat. Neuroendocrinology 18:204, 1975.

19.Melander A, Rerup C: Studies on e thyroid activity in the mouse. Acta Endocrinol 58:202, 1968.

20.Yamada T, Kajihara A, Onaya T, Kobayashi I, Takemura Y, Shichijo K: Studies on acute stimulatory effect of cold on thyroid activity and its mechanism in the guinea pig. Endocrinology 77:968, 1965.

21.Balsam A Leppo, L.E.: Augmentation of the peripheral metabolism of L-triiodothyronine and L-thyroxine after acclimation to cold. Multifocal stimulation of the binding of iodothyronines by tissues. J Clin Invest 53:980, 1974.

22.Galton VA, Nisula BC: Thyroxine metabolism and thyroid function in the cold-adapted rat. Endocrinology 85:79-, 1969.

22a.Puigserver p, Wu Z, Park CW, Graves R, Wright M, Spiegelman BM. A cold-inducible coactivator of nuclear receptors linked to adaptive thermogenesis. Cell 92:892-39,1998.

23.Epstein Y, Udassin R, Sack J: Serum 3,5,3'-triiodothyronine and 3,3',5'-triiodothyronine concentrations during acute heat load. J Clin Endocrinol Metab 49:677, 1979.

24.Ljunggren JG, Klalner G, Tryselius M: The effect of body temperature on thyroid hormone levels in patients with nonthyroidal illness. Acta Med Scand 202:459, 1977.

25.O'Malley BP, Davies TJ, Rosenthal FD: TSH responses to temperature in primary hypothyroidism. Clin Endocrinol 13:87, 1980.

26.Rastogi GK, Malhotra MS, Srivastava MC, et al: Study of the pituitary-thyroid functions at high altitude in man. J Clin Endocrinol Metab 44:447, 1977.

27.Moncloa F, Guerra-Garcia R, Subauste C, Sobrevilla LA, Donayre J: Endocrine studies at high altitude. I. Thyroid function in seal level natives exposed for two weeks to an altitude of 4,300 meters. J Clin Endocrinol Metab 26:1237, 1966.

28.Surks MI, Beckwitt HJ, Chidsey CA: Changes in plasma thyroxine concentration and metabolism, catecholamine excretion, and basal oxygen consumption in man during acute exposure to high altitude. J Clin Endocrinol Metab 27:789, 1967.

28a.Mordes JB, Blume FD, Boyer et al: High-altitude pituitary-thyroid dysfunction on Mount everest. N Engl J Med 308:1135-,1983.

28b.Ramirez G, Herrera R, Pineda D, Bittle PA, Rabb HA, Bercu BB: The effects of high altitude on hypothalamic-pituitary secretory dynamics in man. Clin Endocrinol (oxf) 43:11-18,1995.

29.Mulvey PF, Macaione JMR: Thyroidal dysfunciton during simulated altitude conditions. Fed Proc 23:1243, 1969.

30.Surks MI: Effect of hypoxia and high altitude on thyroidal iodine metaoblism in the rat. Endocrinology 78:307, 1966.

31.Surks MI: Effect of thyrotropin on thyroidal iodine metabolism during hypoxia. Am J Physiol 216:436, 1969.

32.Pazo JH, Houssay AB, Davison TA, Chait RJ: On the mechanism of the thyroid hypertrophy in pinealectomized rats. Acta Physiol Lat Am 18:332, 1968.

33.Singh DV, Turner CW: Effect of light and darkness upon thyroid secretion rate and on the endocrine glands of female rats. Proc Soc Exp Biol Med 131:1296, 1969.

33a.Shavali SS, Haldar C: Effects of continuous light, continuous darkness and pinealectomy on pineal-thyroid-gonadal axis of the female Indian palm squirrel, Funambulus pennati. J Neurol Transm 105:407-13,1998.

Singh DV, Narang GD, Turner CW: Effect of melatonin and its withdrawal on thyroid hormone secretion rate of female rats. J Endocrinol 43:489, 1969.

34a.Uchiyama M, Ishibashi K, Enomoto T, Nakajima T, Shibui K, Hirokawa G, Okawa M: Twenty-four hour profiles of four hormones under constant routine. Psychiatry Clin Neurosci 52:241-3,1998.

35.Martino E, Seo H, Lernmark A, Refetoff S: Ontogenetic pattern of thyrotropin-releasing hormone-like material in rat hypothalamus, pancreas and retina: Selective effect of light deprivation. Proc Natl Acad Sci 77:4345, 1980.

35a.Allan JS, Czeisler CA: Persistence of the circadian thyrotropin rhythmn under constant conditions and after light-induced shifts of circadian phase. J Clin Endocrionol Metab 79:508-,1994.

36.Portnay GI, O'Brian JT, Bush J, al: The effect of starvation on the concentration and binding of thyroxine and triiodothyronine in serum and on the response to TRH. J Clin Endocrinol Metab 39:191-194, 1974.

37.Merimee TJ, Fineberg ES: Starvation-induced alterations of circulating thyroid hormone concentrations in man. Metabolism 25:79, 1976.

38.Carlson HE, Drenick EJ, Chopra IJ, Hershman JM: Alterations in basal and TRH-stimulated serum levels of thyrotropin, prolactin, and thyroid hormones in starved obese men. J Clin Endocrinol Metab 45:707, 1977.

39.Azizi F: Effect of dietary composition on fasting-induced changes in serum thyroid hormones and thyrotropin. 27:935-942, 1978.

40.Scriba PC, Bauer M, Emmert D, et al: Effects of obesity, total fasting and re-alimentation of L-thyroxine (T4), 3,5,3'-L-triiodothyronine (T3), 3,3',5'-L-triiodothyronine (rT3), thyroxine binding globulin (TBG), cortisol, thyrotrophin, cortisol binding globulin (CBG), transferrin, 2-haptoglobin and complement C'3 in serum. 91:629-643, 1979.

40a.Alvero R, Kimzey L, Sebring N, Reynolds J, Loughran M, Nieman L, Olson BR: Effects of fasting on neuroendocrine function and follicle development in lean women. JCEM 83:76-80,1998.

40b.Byerly LO, Heber D: Metabolic effects of triiodothyronine replacement during fasting in obese subjects. JCEM 81:968-76,1996.

41.Vagenakis AG, Portnay GI, O'Brian JT, et al: Effect of starvation on e production and metabolism of thyroxine and triiodothyronine in euthyroid obese patients. J Clin Endocrinol Metab 45:1305, 1977.

42.Suda AK, Pittman CS, Shimizu T, Chambers JB Jr.: The production and metabolism of 3,5,3'-triiodothyronine and 3,3',5'-triiodothyronine in normal and fasting subjects. J Clin Endocrinol Metab 47:1311, 1978.

43.Stokholm KH: Decrease in serum free triiodothyronine, thyroxine-binding globulin and thyroxine-binding prealbumin whilst taking a very-low-calorie diet. Int J Obest 4:133, 1980.

44.Balsam A, Ingbar SH: The influence of fasting, diabetes, and several pharmacological agents on the pathways of thyroxine metabolism in rat liver. J Clin Invest 62:415, 1978.

45.Chopra IJ, Geola F, Solomon DH, Maciel RMB: 3',5'-diiodothyroxine in health and disease: Studies by a radioimmunoassay. J Clin Endocrinol Metab 47:1198-1207, 1978.

46.Chopra IJ: A radioimmunoassay for measurement of 3'-monoiodothyronine. J Clin Endocrinol Metab 51:117-123, 1980.

47.Pangaro L, Burman KD, Wartofsky L, et al: Radioimmunoassay for 3,5-diiodothyronine and evidence for dependence on conversion from 3,5,3'-triiodothyronine. J Clin Endocrinol Metab 50:1075-1081, 1980.

47a. Van der Geyten S, Van Rompaey E, Sanders JP, Visser TJ, Kuhn ER, Darras VM : Regulation of thyroid hormone metabolism during fasting and refeeding in chicken. Gen Comp Endocrinol 116:272-80,1999

48.Pittman CS, Shimizu T, Burger A, Chambers JB Jr.: The nondeiodinative pathways of thyroxine metabolism: 3,5,3',5'-tetraiodothyroacetic acid turnover in normal and fasting human subjects. J Clin Endocrinol Metab 50:712-716, 1980.

49.Balsam A, Ingbar SH: Observations on the factors that control the generation of triiodothyronine from thyroxine in rat liver and the nature of the defect induced by fasting. J Clin Invest 63:1156, 1979.

50.Chopra IJ: Alterations in monodeiodination of iodothyronines in the fasting rat: Effects of reduced nonprotein sulfhydryl groups and hypothyroidism. Metabolism 29:161, 1980.

51.Gavin LA, McMahon FA, Moeller M: Dietary modification of thyroxine deiodination in rat liver is notmediated by hepatic sulfhydryls. J Clin Invest 65:943, 1980.

52.Burman KD, Dimond RC, Harvey GS, et al: Glucose modulation of alterations in serum iodothyronine concentrations induced by fasting. Metabolism 28:291, 1979.

53.Danforth E, Sims EAH, Horton ES, Goldman RF: Correlation of serum triiodothyronine concentrations with dietary composition. Diabetes 24:406, 1975.

54.Harris ARC, Fang SL, Vagenakis AG, Braverman LE: Effect of starvation, nutriment replacement, and hypothyroidism on in vitro hepatic T4 to T3 conversion in the rat. Metabolism 27:1680, 1978.

55.Burger AG, Berger M, Wimpfheimer K, Danforth E: Interrelationships between energy metabolism and thyroid hormone metabolism during starvation in the rat. Acta Endocrinol 93:322, 1980.

56.Gardner DF, Kaplan MM, Stanley CA, Utiger RD: Effect of triiodothyronine replacement on the metabolic and pituitary responses to starvation. N Engl J Med 300:579, 1979.

57.Silva JE, Dick TE, Larsen PR: The contribution of local tissue thyroxine monodeiodination to nuclear 3,5,3'-triiodothyronine in pituitary, liver and kidney of euthyroid rats. Endocrinology 103:1196, 1978.

58.Cheron RG, Kaplan MM, Larsen PR: Physiological and pharmacological influences on thyroxine to 3,5,3'-triiodothyronine conversion and nuclear 3,5,5'-triiodothyronine binding in rat anterior pituitary. J Clin Invest 64:1402, 1979.

58a.Diano S, Naftolin F, Goglia F, Horvath TL: Fating-induced increase in Type II iodothyronine deiodinase activity and messenger ribonucleic acid levels is not reversed by thyroxine in the rat hypothalamus. Edocrinology 139:2879-84,1998.

59.Harris ARC, Fang SL, Azizi F, Lipworth L, Vagenakis AG, Braverman LE: Effect of starvation on hypothalamic-pituitary-thyroid function in the rat. Metabolism 27:1074, 1978.

60.Morley JE, Russell RM, Reed A, Carney EA, Hershman JM: The interrelationship of thyroid hormones with vitamin A and zinc nutritional status in patients with chronic hepatic and gastrointestinal disorders. Am J Clin Nutr 34:1489, 1981.

60a.von Haasteren GA, Linkels E, van Toor H, Klootwijk W, Kaptein E, de Jong FH, Reymond MJ, Visser TJ, de Greef WJ: Effects of long term food reduction on the hypothalamic-pituitary-thyroid axis in male and female rats. J Endocrinol 150:169-78,1996.

60b.von Haasteren GA, Linkels E, Klootwijk W, van Toor H, Rondeel JM, Themmen AP, de Jong FH, Valentijn K, Vaudry H, Bauer K, et al: Starvation induced changes in the hypothalamic content of prothyrotropin-releasing hormone (proTRH) mRNA and the hypothalmic release of proTRH derived peptides:role of the adrenal gland. J Endocrinol 145:143-53,1995.

61.Shambaugh GE III, Wilber JF: The effect of caloric deprivation upon thyroid function in the neonatal rat. Endocrinology 94:1145, 1974.

62.DeGroot LJ, Coleoni AH, Rue PA, Seo H, Martino E, Refetoff S: Reduced nuclear triiodothyronine receptors in starvation-induced hypothyroidism. Biochem Bioophys Res Commun 79:173, 1977.

62a.Tagami T, Nakamura H, Sasaki S, Miyoshi Y, Nakao K: Starvation-induced decrease in the maximal binding capacity for triiodothyronine of the thyroid hormone receptor due to a decrease on the receptor protein. Metabolism 45:970-3,1996.

63.Schussler GC, Orlando J: Fasting decreases triiodothyronine receptor capacity. Science 199:686, 1978.

64.Buergi V, Larsen PN: Nuclear triiodothyronine binding in mononuclear leukocytes in normal subjects and obese patients before and after fasting. J Clin Endocrinol Metab 54:1199, 1982.

65.Jung RT, Shetty PS, James WPT: Nutritional effects on thyroid and catecholamine metabolism. Clin Sci 58:183, 1980.

66.Huang HS, Pittman CS: Effects of thyroid hormone evaluated by cardiac systolic time interval in fasted subjects. J Formosan Med Ass 83:1087-93, 1994.

67.Vignati L, Finley RJ, Haag S, Aoki TT: Protein conservation during prolonged fast: a function of triiodothyronine levels. Trans Assoc Am Physicians 16:169, 1978.

68.Carter WJ, Shakir KM, Hodges S, Faas FH, Wynn JO: Effect of thyroid hormone on metabolic adaptation to fasting. Metabolism 24:1177, 1975.

69.Wartofsky L, Burman D: Alterations in thyroid function in patients with systemic illness: The "euthyroid sick syndrome". Endocr Rev 3:164, 1982.

70.Ingenbleek Y, Malvaux P: Peripheral turnover of thyroxine and related parameters in infant protein-calorie malnutrtion. Am J Clin Nutr 33:609, 1980.

71.van der Westhuyzen JM: Plasma-T3 assay in Kwashiorkor. Lancet 2:965, 1973.

72.Chopra IJ, Smith SR: Circulating thyroid hormones and thyrotropin in adult patients with protein-calorie malnutrition. J Clin Endocrinol Metab 40:221, 1975.

72a.Orbak Z, Akin Y, Varoglu E, Tan H: Serum thyroid hormone and thyroid gland weight measurements in protein-energy malnutrition. J Pediatr Endocrinol Metab 11:719-24,1998.

72b.Turkay S, Kus S, Gokalp A, Baskin E, Onal A: Effects of protein energy malnutrition on circulating thyroid hormones. Indian Pediatr 32:193-7,1995.

73.Ingenbleek Y, Beckers C: Thyroidal iodide clearance and radioiodide uptake in protein-calorie malnutriton. Am J Clin Nutr 31:408, 1978.

74.Pimstone B, Becker D, Hendricks S: TSH response to synthetic thyrotropin-releasing hormone in human protein-calorie malnutrition. J Clin Endocrinol Metab 36:779, 1973.

75.Tulp OL, Krupp PP, Danforth E Jr., Horton ES: Characteristics of thyroid function in experimental protein malnutrion. J Nutr 109:1321, 1979.

76.Falconer IR, Marchant B: Thyroxine utilization in lambs in natural and controlled environments. J Endocrinol 46:363, 1970.

77.Danforth E Jr.,, Horton ES, O'Connell M, et al: Dietary-induced alterations in thyroid hormone metabolism during overnutrition. J Clin Invest 64:1336, 1979.

78.Bray GA, Fisher DA, Chopra IJ: Relation of thyroid hormones to bodyweight. Lancet 1:1206, 1976.

79.Glass AR, Burman KD, Dahms WT, Boehm TM: Endocrine function in human obesity. Metabolism 30:89, 1981.

80.Robison LM, Sylvester PW, Birkenfeld P, Lang JP, Bull RJ Comparison of the effects of iodine and iodide on thyroid functioinn in humans. J Toxicol Environ Health 55:93-106,1998.

80a.Uyttersprot N, Pelgrims N, Carrasco N, Gervy C, Maenhaut C, Dumont JF, Miot F: Moderate doses of iodid in vivo inhibit cell proliferation and the expression of thyroperoxidase and the Na+/I- symporter mRNAs in dog thyroid. Moll Cell Endocrinol 131:195-203,1997.

80b.Pregliasco L, Bocanera L, Krawiec L, Siberschmidt D, Pisarev M, Juvenal G: Effects of iodid on thyroglobulin biosynthesis in FRTL-5 cells. Thyroid 6:319-23,1996

81.Vagenakis AG, Downs P, Braverman LE, Burger A, Ingbar SH: Control of thyroid hormone secretion in normal subjects receiving iodides. J Clin Invest 52:528, 1973.

Vagenakis AG, Rapoport B, Azizi F, et al: Hyper-response to thyrotropin-releasing hormone accompanying small decreases in serum thyroid hormone concentration. J Clin Invest 54:913-918, 1974.

82a.Vitale M, DiMatola T, D”Ascoli F, Salzano S, Bogazzi F, Frnzi G, Martino E, Rossi G. Iodide excess induces apoptosis through a p53 independent mechanism involving oxidative stress. Endocrinology 141:598-605, 2000

82b.Burikhanov RB, Matsuzaki S. Excess iodine induces apoptosis in the thyroid of goitrogen-pretreated rats in vivo. Thyroid 10:123-9,2000

83.Braverman LE, Ingbar SH, Vagenakis AG, Adams L, Maloof F: Enhanced susceptibility to iodide myxedema in patients with Hashimoto's disease. J Clin Endocrinol Metab 32:515, 1971.

84.Braverman LE, Woeber KA, Ingbar SH: Induction of myxedema by iodide in patients euthyroid after radioiodine or surgical treatment of diffuse toxic goiter. N Engl J Med 281:816, 1969.

85.Azizi F, Bentley D, Vagenakis A, et al: Abnormal thyroid function and response to iodides in patients with cystic fibrosis. Trans Assoc Am Physicians 87:111, 1974.

86.Begg TB, Hall R: Iodide goitre and hypothyroidism. Q J Med 32:351, 1963.

87.Pasternak DP, Socolow EL, Ingbar SH: Synergistic interaction of phenazone and iodide on thyroid hormone biosynthesis in the rat. Endocrinology 84:769, 1969.

88.Shopsin B, Shenkman L, Blum M, Hollander CS: Iodine and lithium-induced hypothyroidism. Documentation of synergism. Am J Med 55:695, 1973.

89.Milne K, Greer MA: Comparison of the effects of propylthiouracil and sulfadiazine on thyroidal biosynthesis and the manner by which they are influenced by supplemental iodide. Endocrinology 71:580, 1962.

90.Vagenakis AG, Ingbar SH, Braverman LE: The relationship between thyroglobulin synthesis and intrathyroid iodine metabolism as indicated by the effects of cycloheximde in the rat. Endocrinology 94:1669, 1974.

90a.Stanbury JB, Ermans AE, Bourdoux T, Todd C, Oken E, Tonglet R,Vidor G, Braverman LE, Medeiros-Neto G: Iodine induced hyperthyroidism: occurrence and epidemiology. Thyroid 8:83-100,1998.

91.Jackson AS: Iodine hyperthyroidism: An analysis of fifty cases. Boston Med Surg J 193:1138, 1925.

92.Vidor GI, Stewart JD, Wall JR, Wangel A, Hetzel BS: Pathogenesis of iodide induced thyrotoxicosis: Studies in northern Tasmania. J Clin Endocrinol Metab 37:901, 1973.

93.Ermans AM, Camus M: Modifications of thyroid function induced by chronic administration of iodide in the presence of "autonomous" thyroid tissue. Acta Endocrinol 70:463, 1972.

94.Vagenakis AG, Wang CA, Burger A, et al: Iodide-induced thyrotoxicosis in Boston. N Engl J Med 287:523-527, 1972.

95.Suzuki H, Higuchi T, Sawa K, Ohtaki S, Horiuchi Y: "Endemic coast goitre" in Hokkaido, Japan. Acta Endocrinol 50:161, 1965.

96.Wartofsky L: Low remission after therapy for Graves' disease: Possible relation of dietary iodine with antithyroid therapy results. JAMA 226:1083, 1973.

97.Boyle JA, Greig WR, Fulton S, Dalakos TG: Excess dietary calcium and human thyroid function. J Endocrinol 34:532, 1966.

97a. Singh N, Singh PN, Hershman JM: Effect of calcium carbonate on the absorption of levothyroxine. JAMA 283:2822-5,2000

97b.Singh N, Weisler, SL, Hershman JM The acute effect of calcium carbonate on the intestinal absoprption of levothyroxine. Thyroid 11:967-971; 2001

98.Bloomfield RA, Welsch CW, Garner GB, Muhrer ME: Effect of dietary nitrate on thyroid function. Science 134:1690, 1961.

99.Clode W, Sobral JM, Baptista AM: Bromine interference in iodine metabolism and its goitrogenic action. R. Pitt-Rivers (eds), Advances in Thyroid Research, Pergamon Press, New York, pp. 65,1961.

99a.Vobecky M, Babicky A, Lerner J, Svandova E: Interaction of bromine with iodine in the rat thyroid gland at enhanced bromide intake. Biol Trace elem Res 54:207-12,1996.

99b.Velicky J, Titlbach M, Duskova J, Vobecky M, Strbak V, Raska I: Potassium bromide and the thyroid gland of the rat:L morphology and immunohistochemistry, RIA and INAA analysis. Anat Anz 179:421-31,1997.

100.Bach I, Braun S, Gati T, Kertai P, Sós J, Udvardy A: Effect of rubidium on the thyroid. R. Pitt-Rivers (eds), Advances in Thyroid Research, Pergamon Press, New York, pp. 505,1961.

101.Galletti PM, Joyet G: Effect of fluorine on thyroidal iodine metaoblism in hyperthyroidism. J Clin Endocrinol Metab 18:1102, 1958.

102.Gedalia I, Brand N: The relationship of fluoride and iodine in drinking water in the occurrence of goiter. Arch Int Pharmacodyn Ther 142:312, 1963.

103.Siddiqui AH: Incidence of simple goitre in areas of endemic fluorosis. J Endocrinol 20:201, 1960.

104.Day TK, Powell-Jackson PR: Fluoride water hardness, and endemic goiter. Lancet 1:1135, 1972.

Paley KR, Sobel ES, Yalow RS: Effect of oral and intravenous cobaltous chloride on thyroid function. J Clin Endocrinol Metab 18:850, 1958.

105a.Stangl GI, Schwartz FJ, Kirchgessner M. Cobalt deficiency effects on trace elements, hormones and enzymes involved in energy metabolsim in cattle. Int J Vitam Nutr Res 69:120-6,1999

105b.Barceloux, DG. Cobalt. J Toxicol Clin Toxicol 37:201-6,1999

106.Pimentel-Malaussera E, Roche M, Lavrisse M: Treatment of eight cases of hyperthyroidism with cobaltous chloride. JAMA 167:1719, 1958.

106a.Gupta P, Kar A: Role of ascorbic acid in cadmium-induced thyroid dysfunction and lipid peroxidation. J Appl Toxicol 18:317-20,1998.

106b.Paier B, Pavia MA Jr, Hansi C, Noli MI, Hagmuller K, Zaninovich AA: Cadmium inhibits the in vitro conversion of thyroxine to triiodothyronine in rat brown adipose tissue. Bull Environ Contam Toxicol 59:164-70,1997.

106c.Gupta P, Chaurasia SS, Maiti PK, Kar A: Cadmium induces alterations in extrathyroidal conversion of thyroxine to triiodothyronine 5” monodeiodinase in male mouse. Horm Metab Res 29:151-2,1997

107.Pousset GB J., Berthezene F, Tourniare J, Devic M: Myxoedeme au lithium. Ann Endocrinol 34:549, 1973.

108.Berens SC, Bernstein RS, Robbins J, Wolff J: Antithyroid effects of lithium. J Clin Invest 49:1357, 1970.

109.Spaulding SW, Burrow GN, Bermudez F, Himmelhoch JM: The inhibitory effect of lithium on thyroid hormone release in both euthyroid and thyrotoxic patients. J Clin Endocrinol Metab 35:905, 1972.

110.Carlson HE, Temple R, Robbins J: Effect of lithium on thyroxine disappearance in man. J Clin Endocrinol Metab 36:1251, 1973.

110a.Lazarus, JH. The effects of lithium therapy on thyroid and thyrotropin-releasing hormone. Thyroid 8:909-13,1998.

110b.Tasevski V, Been D, King M, Luttrell B, Simpson A: Mitogenic effects in FRTL-5 cells can be reversed by blocking de novo cholesterol synthesis and subsequent signal transduction. Thyroid 2000:305-11, 2000.

111.Burman KD, Diamond RC, Earll JM, Wright FD, Wartofsky L: Sensitivity to lithium in treated Graves' disease: Effects on serum T4, T3 and reverse T3. J Clin Endocrinol Metab 43:606, 1976.

112.Blomqvist N, Lindstedt G, Lundberg PA, Walinder J: No inhibition by Li+ of thyroxine monodeiodination to 3,5,3'-triiodothyronine and 3,3',5'-triiodothyronine (reverse triiodothyronine). Clin Chim Acta 79:457, 1977.

113.Linquette M, Lefebre J, Van Parys C, Wemeau JL: Le lithium dans le traitement des thyrotoxicoses. Ann d'Endocrinol 39:15, 1978.

114.Andersen BF: Iodide perchlorate discharge test in lithium-treated patients. Acta Endocrinol 73:35, 1973.

115.Berens SC, Wolff J, Murphy DL: Lithium concentration by the thyroid. Endocrinology 87:1085, 1970.

116.Wolff J, Berens SC, Jones AB: Inhibition of thyrotropin-stimulated adenyl cyclase activity of beef thyroid members by low concentration of lithium ion. Biochem Biophys Res Commun 39:77, 1970.

117.Bhattacharya B, Wolff J: Stabilization of microtubules by lithium ion. Biochem Biophys Res Commun 73:383, 1976.

117a.Baumgartner A, Pinna G, Hiedra L, Gaio U, Hessenius C, Campos-Barros A, Eravci M, Prengel H, Thoma R, Meinhold H. Effects of lithium and carbamazapine on thyroid hormone metabolism in rat brain. Neuropsychopharmacology 16:25-41,1997.

117b. Hahn CG, Pawlyk AC, Whybrow, PC Gyulai L, Tejani-Butt SM. Lithium administration affects gene expression of thyroid hormone receptors in rat brain. Life Sci 64:1793-802, 1999

118.Lazarus JH, Joh R, Bennie EH, et al: Lithium therapy and thyroid function: A long term study. Psych Med 11:85-92, 1981.

118a.Kirov G. Thyroid disorders in lithium-treated patients. J Affect Disord 50:33-40,1998

118b.Johnston AM, Eagles JM. Lithium-associated hypothyroidism. Prevalence and risk factors. Br J Psychiatry 175:336-9,1999

118c.Kusalic M, Engelsmann F. Effect of lithium maintenance therapy on thyropid and parathyroid function. J Psychatry Neurosci 24:227-33,1999

119.Segal RL, Rosenblatt S, Eliasoph I: Endocrine exophthalmos during lithium therapy of manic-depressive disease. N Engl J Med 289:136, 1973.

119a.Berry MJ, Banu L, Larsen PR: Type I iodothyronine deiodinase is a selenocystein-containing enzyme. Nature 349:438-,1991.

119b.Olivieri O, Girelli D, Stanzial AM, Rossi L, Bassi A, Corrocher R: Selenium, sinc and thyroid hormones in healthy subjects: low T3/T4 ratio in the elderly is related to selenium status. Biol Trace Elem Res 51:31-41,1996.

119c.Kohrle, J. The trace element selenium and the thyroid gland. Biochimie 81:527-33, 1999

119d.Hotz CS, Fitzpatrick DW, Trick KD, L’Abbe MR: Dietary iodine and selenium interact to affect thyroid hormone metabolism. J Nutr 127:1214-8,1997

119e.Mitchell JH, Nicol F, Beckett GJ, Arthur JR: Selenium and iodine deficiencies: effects on brain and brown adipose tisse seleneoenzyme activity and expression. J Endocrinol 155:255-63,1997

119f.Zimerman MB, Adou P, Torresani T, Zeder C, Hurrell RF. Effect of iodized oil on thyroid size and thyroid hormone metabolism with concurrent selenium and iodine deficiency. Eur J Clin Nutr. 54:209-13, 2000

120.Kracht J: Fright-thyrotoxicosis in the wild rabbit, a model of thyrotrophic alarm-reaction. Acta Endocrinol 15:355, 1954.

121.Falconer IR, Hetzel BS: Effect of emotional stress and TSH on thyroid vein hormone level in sheep with exteriorized thyroids. Endocrinology 75:42, 1964.

122.Haibach H, McKenzie JM: Increased free thyroxine postoperatively in the rat. Endocrinology 81:435, 1967.

123.Hagenfeldt I, Melander A, Thorell J, Tibblin S, Westgren U: Active and inactive thyroid hormone levels in elective and acute surgery. Acta Chir Scand 145:77, 1979.

124.Chan V, Wang C, Yeung RTT: Pituitary-thyroid responses to surgical stress. Acta Endocrinol 88:490, 1978.

125.Socolow EL, Woeber KA, Purdy RH, Holloway MT, Ingbar SH: Preparation of I131 labeled human serum prealbumin and its metabolism in normal and sick patients. J Clin Invest 44:1600, 1976.

126.Brandt MR, Skovsted L, Kehlet H, Hansen JM: Rapid decrease in plasma-triiodothyronine during surgery and epidural analgesia independent of afferent neurogenic stimuli and of cortisol. Lancet 2:1333, 1976.

127.Tingley JO, Morris AW, Hill SR, Pittman JA: The acute thyroid response to emotional stress. Ala J Med Sci 2:297, 1965.

128.Cohen KL, Swigar ME: Thyroid function screening in psychiatric patients. JAMA 242:254, 1979.

129.Levy RP, Jensen JB, Laus VG, Agle DP, Engel IM: Serum thyroid hormone abnormalities in psychiatric disease. Metabolism 30:1060, 1981.

130.Spratt DI, Pont A, Miller MB, McDougall IR, Bayer MF, McLaughlin WT: Hyperthyroxinemia in patients with acute psychiatric disorders. Am J Med 73:41, 1982.

131.Chesney AM, Clawson TA, Webster B: Endemic goitre in rabbits. I. Incidence and characteristics. Johns Hospkins Hosp Bull 43:261, 1928.

132.Ermans AM, Delange F, Van Der Velden M, Kinthaert J: Possible role of cyanide and thiocyanate in the etiology of endemic cretinism. J. B. Stanbury and R. L. Kroc (eds), Human Development and the Thyroid Gland. Relation to Endemic Cretinism, Plenum Press, New York, pp. 455,1972.

133.Monekasso GL, Wilson J: Plasma thiocyanate and vitamin B12 in Nigerian patients with degenerative neurological disease. Lancet 1:1062, 1971.

134.Delange F, Ermans AM: Role of a dietary goitrogen in the etiology of endemic goiter on Idjwi Island. Am J Clin Nutr 24:1354, 1971.

135.Delange F, Thilly C, Ermans AM: Iodine deficiency, a permissive condition in the development of endemic goiter. J Clin Endocrinol Metab 28:114, 1968.

136.Langer P, Greer MA: Antithyroid activity of some naturally occurring isothiocyanates in vitro. Metabolism 17:596, 1968.

137.Langer P: Antithyroid action in rats of small doses of some naturally occurring compounds. Endocrinology 79:1117, 1966.

138.Clements FW, Wishart JW: A thyroid-blocking agent in the etiology of endemic goiter. Metabolism 5:623, 1956.

139.Peltola P: The goitrogenic effect of milk obtained from the region of endemic goitre in Finland. R. Pitt-RIvers (eds), Advances in Thyroid Research, Pergamon Press, New York, pp. 10,1961.

140.Peltola P, Krusius FE: Effect of cow's milk from the goitre endemic district of Finland on thyroid function. Acta Endocrinol 33:603, 1960.

141.Kilpatrick R, Broadhead GD, Edmonds CJ, Munro DS, Wilson GM: Studies on goitre in the Sheffield region. R. Pitt-Rivers (eds), Advances in Thyroid Research, Pergamon Press, New York, pp. 273,1961.

141a.Laurberg P, Andersen S, Knudsen N, Ovesen L, Nohr SB, Pedersen IB: THiocyanate in food and iodine in milk: From domestic animal feeding to improved understanding of cretinism. Thyroid 12:897-902; 2002

142.Astwood EB, Greer MA, Ettlinger MG: L-5-Vinyl-2-thiooaxazolidone, an antithyroid compound from yellow turnip and from bassica seeds. J Biol Chem 181:121, 1949.

143.Greer MA: The isolation and identification of progoitrin from bassica seed. Arch Biochem Biophys 99:369, 1962.

144.Langer P, Michajlovskij N: Studies on the antithyroid activity of naturally occurring L-5-vinyl-2-thiooxazolidone and its urinary metabolite in rats. Acta Endocrinol 62:21, 1969.

145.Krusius FE, Peltola P: The goitrogenic effect of naturally occurring L-5-vinyl- and L-5-phenyl-2-thio-oxazolidone in rats. Acta Endocrinol 53:342, 1966.

146.Arstila A, Krusius FE, Peltola P: Studies on the transfer of thio-oxazolidone-type goitrogens into cow's milk in goiter endemic districts of Finland and in experimental conditions. Acta Endocrinol 60:712, 1969.

147.Barzelatto J, Beckers C, Stevenson C, et al: Endemic goiter in Pedgregoso (Chile). I. Description and fuction studies. Acta Endocrinol 54:577, 1967.

148.Linazasoro JM, Sanchez-Martin JA, Jiminez-Diaz C: Goitrogenic effect of walnuts. Lancet 2:501, 1966.

149.Gaitan E, Wahner HW, Correa P, et al: Endemic goiter in the Cauca Valley: I. Results and limitations of twelve years of iodine prophylaxis. J Clin Endocrinol Metab 28:1730, 1968.

149a. Abel Gadir WS, Adam SE: Development of goitre and enterohepatonephropathy in Nubian Goats fed with pearl millet (pennisetum typhoides) Vet J 157: 178-85,1999

150.McCarrison R: The goitrogenic action of soybean and ground-nut. Indian J Med Res 21:179, 1933.

151.Van Wyk JJ, Arnold MB, Wynn J, Pepper F: The effects of a soybean product on thyroid functions in humans. Pediatrics 24:752-760, 1959.

152.Pinchera A, MacGillivray MH, Crawford JD, Freeman AG: Thyroid refractoriness in an athyrotic cretin fed soybean formula. N Engl J Med 273:83-86, 1965.

153.Yamada T: Effect of fecal loss of thyroxine on pituitary-thyroid feedback control in the rat. Endocrinology 82:327, 1968.

154.Bray GA: Increased sensitivity of the thyroid in iodine-depleted rats to the goitrogenic effects of thyrotropin. J Clin Invest 47:1640, 1968.

155.Bull GM, Fraser R: Myxedema from resorcinol ointment applied to leg ulcers. Lancet 1:851, 1950.

156.Selenkow HA, Rivera A, Thorn GW: The effects of amphenone on thyroid function in man. J Clin Endocrinol Metab 17:1131, 1957.

157.Pittman JA, Brown RW: Antithyroid and antiadrenocortical activity of aminoglutethimide. J Clin Endocrinol Metab 26:1014, 1966.

158.Rallison ML, Kumagai LF, Tyler FH: Goitrous hypothyroidism induced by aminoglutethmide, anticonvulsant drug. J Clin Endocrinol Metab 27:265, 1967.

159.Jukes TH, Shaffer CB: Antithyroid effects of aminotriazole. Science 132:296, 1960.

160.Pittman JA, Brown RW: Antithyroid action of amphenidone. J Clin Endocrinol Metab 22:100, 1962.

161.Current JV, Hales IB, Dobyns BM: The effect of 2,3-dimercaptopropanol (BAL) on thyroid function. J Clin Endocrinol Metab 20:13, 1960.

162.Sharpe AR Jr.: Inhibition of thyroidal ¹³¹I uptake by parabromdylamine maleate. J Clin Endocrinol Metab 21:739, 1961.

163.Linsk JA, Paton BC, Persky M, Isaacs M, Kupperman HS: The effect of phenylbutazone and a related analogue (G25671) upon thyroid function. J Clin Endocrinol Metab 17:416, 1957.

164.Wyngaarden JB, Stanbury JB, Rapp B: The effects of iodide, perchlorate, thiocyanate, and nitrate administration upon the iodide concentrating mechanism of the rat thyroid. Endocrinology 52:568, 1953.

165.Ermans AM, Goossens F: Influence du perchlorate et du methimazol sur l'excretion urinaire de l'iode chez l'homme. Arch Int Pharmacodyn Ther 132:487, 1961.

166.Stewart RDH, Murray IPC: An evaluation of the perchlorate discharge test. J Clin Endocrinol Metab 26:1050, 1966.

167.Scranton JR, Nissen WM, Halmi NS: The kinetics of the inhibition of thyroidal iodide accumulation by thiocyanate: A reexamination. Endocrinology 85:603, 1969.

168.Frohman LA, Klocke FJ: Recurrent thiocyanate intoxication, with pancytopenia, hypothyroidism, and psychosis. N Engl J Med 268:701, 1963.

169.Taurog A, Potter GD, Chaikoff IL: Conversion of inorganic ¹³¹I to organic ¹³¹I by cell free preparations of thyroid tissue. J Biol Chem 213:119, 1955.

170.Anbar M, Guttman S, Lewitus Z: Effect of monofluorosulphanate, difluorophosphate, and F borate ions on the iodine uptake of the thyroid gland. Nature 183:1517, 1959.

171.Anbar M, Guttman S, Lewitus Z: The accumulation of fluoroborate ions in thyroid glands of rats. Endocrinology 66:888, 1960.

172.Chow SY, Chang LR, Yen MS: A comparison between the uptakes of radioactive perchlorate and iodide by rat and guinea-pig thyroid glands. J Endocrinol 45:1, 1969.

173.Crooks J, Wayne EJ: A comparison of potassium perchlorate, methylthiouracil, and carbimazole in the treatment of thyrotoxicosis. Lancet 1:401, 1960.

174.Michajlovskij N, Langer P: Increase of serum free thyroxine following the administration of thiocyanate and other anions in vivo and in vitro. Acta Endocrinol 75:707-716, 1974.

174a.Li FX, Squartsoff L, Lamm SH: Prevalence of thyroid disease in Nevada counties with respect to perchlorate in drinking water. J Occup Environ Med 43:630-4;2001

174b.Morgan JW, Cassady RE: Community cancer assessment in response to long-time exposure to perchlorate and trichloroethylene in drinking water. J Occup Environ Med 44:616-21;2002

174c.Kelsh MA, Buffler PA, Daaboul JJ, Rutherford GW, Lau EC, Barnard JC, Exuzides AK, Madl AK, Palmer LG, Lorey FW: Primary congenital hypothyroidism, newborn thyroid function, and environmental perchlorate exposure among residents of a Southern California community. J Occup Environ Med 45:1116-27;2003

175.Rosenberg IN: The antithyroid activity of some compounds that inhibit peroxidase. Science 116:503, 1952.

176.DeGroot LJ, Davis AM: Studies on the biosynthesis of iodotyrosines: A soluble thyroidal iodide-peroxidase tyrosine-iodinase system. Endocrinology 70:492, 1962.

177.Yamazaki E, Noguchi A, Slingerland DW: Effect of methylthiouracil and iodide on the iodinated constitutents of thyroid tissue in Graves' disease. J Clin Endocrinol Metab 20:889, 1960.

178.Iino S, Yamada T, Greer MA: Effect of graded doses of propylthiouracil on biosynthesis of thyroid hormones. Endocrinology 68:582, 1961.

179.Mulvey PF Jr., Slingerland DW: The in vitro stimulation of thyroidal activity by propylthiouracil. Endocrinology 70:7, 1962.

180.Selenkow HA, Collaco FM: Clinical pharmacology of antithyroid compounds. Clin Pharmacol Ther 2:191, 1961.

181.Astwood EB: Mechanisms of action of various antithyroid compounds. Ann NY Acad Sci 50:419, 1949.

182.Maloff F, Spector L: The desulfuration of thiourea by thyroid cytoplasmic particulate fractions. J Biol Chem 234:949, 1959.

183.Maloof F, Soodak M: Cleavage of disulfide bonds in thyroid tissue by thiourea. J Biol Chem 236:1689, 1961.

184.Mitchell ML, Sanchez-Martin JA, Harden AB, O'Rourke ME: Failure of thiourea to prevent hormone synthesis by the thyroid gland of man and animals treated with TSH. J Clin Endocrinol Metab 21:157, 1961.

185.Mayberry WE, Astwood EB: The effect ofpropylthiouracil on the intrathyroid metaoblism of iodine in rats. J Biol Chem 235:2977, 1960.

186.Escobar del Rey F, Morreale de Escobar G: The effect of propylthiouracil, methylthiouracil and thiouracil on the peripheral metabolism of L-thyroxine in thyroidectomized L-thyroxine maintained rats. Endocrinology 69:456-465, 1961.

187.Van Middlesworth L, Jones SL: Interference with deiodination of some thyroxine analogues in the rat. Endocrinology 69:1085, 1961.

188.Escobar del Rey F, Morreale de Escobar G, Garcia-Garcia MD, Mouriz Garcia J: Increased secretion of thyrotrophic hormone in rats with a depressed peripheral deiodination of thyroid hormone and a normal or high plasma PBI. Endocrinology 71:859, 1962.

189.Slingerland DW, Burrows BA: Inhibition by propylthiouracil of the peripheral metabolism of radiothyroxine. J Clin Endocrinol Metab 22:511, 1962.

190.Furth ED, Rives K, Becker DV: Nonthyroidal action of propylthiouracil in euthyroid, hypothyroid, and hyperthyroid man. J Clin Endocrinol Metab 26:239-246, 1966.

191.Oppenheimer JH, Schwartz HL, Surks MI: Propylthiouracil inhibits the conversion of L-thyroxine to L-triiodothyronine. An explanation of the antithyroxine effect of propylthiouracil and evidence supporting the concept that triiodothyronine is the active hormone. J Clin Invest 51:2493-2497, 1972.

192.Stasilli NR, Kroc RL, Edlin R: Selective inhibition of the calorigenic activities of certain thyroxine analogues with chronic thiouracil treatment in rats. Endocrinology 66:872, 1960.

193.Bray GA, Hildreth S: Effect of propylthiouracil and methimazole on the oxygen consumption of hypothyroid rats receiving thyroxine or triiodothyronine. Endocrinology 81:1018, 1967.

194.Ruegamer WR, Warren JS, Barstow M, Beck W: Effects of thiouracil on rat liver alpha-glycerophosphate dehydrogenase and serum PBI responses to L-thyroxine. Endocrinology 81:277, 1967.

195.Chopra IJ, Solomon DH, Chopra U, Wu SY, Fisher DA, Nakamura Y: Pathways of metabolism of thyroid hormones. Recent Prog Horm Res 34:521, 1978.

196.Pittman JA, Beschi RJ, Smitherman TC: Methimazole: Its absorption and excretion in man and tissue distribution in rats. J Clin Endocrinol Metab 33:182, 1971.

197.Marchant B, Alexander WD, Lazarus JH, Lees J, Clark DH: The accumulation of 35S antithyroid drugs by the thyroid gland. J Clin Endocrinol Metab 34:847, 1972.

198.Krieger DT, Moses A, Ziffer H, Gabrilove JL, Soffer LJ: Effect of acetazoleamide on thyroid metabolism. Am J Physiol 196:291, 1959.

199.Gabrilove JL, Alvarez AA, Soffer LJ: Effect of acetazoleamide (Diamox) on thyroid function. J Appl Physiol 13:491, 1958.

200.Brown J, Solomon DH: Mechanism of antithyroid effects of a sulfonylurea in the rat. Endocrinology 63:473, 1958.

201.Tranquade RE, Solomon DH, Brown J, Greene R: The effect of ora hypoglycemic agents on thyroid function in the rat. Endocrinology 67:293, 1960.

202.Nikkilä EA, Jakobson T, Josipii SG, Karlsson K: Thyroid function in diabetic patients under long-term sulfonylurea treatment. Acta Endocrinol 33:623, 1960.

203.Skinner NS Jr., Hayes RL, Hill SR Jr.: Studies on the use of chlorpropamide in patients with diabetes mellitus. Ann NY Acad Sci 74:830, 1959.

204.Hunton RB, Wells MV, Skipper EW: Hypothyroidism in diabetics treated with sulphonylurea. Lancet 2:449, 1965.

205.Hershman JM, Konerding K: Effects of sulfonylurae drugs on the thyroid and serum protein binding of thyroxine in the rat. Endocrinology 83:74, 1968.

205a.Hagmer L: Polychlorinated biphenyls and thyroid status in humans: a review. Thyroid 13:1021-1028;2003

206.Azizi F, Vagenakis AG, Portnay GI, et al: Thyroxine transport and metabolism in methadone and heroin addicts. Ann Intern Med 80:194-199, 1974.

207.McKerron CG, Scott RL, Asper SP, Levy RI: Effects of clofibrate (Atromid S) on the thyroxine-binding capacity of thyroxine-binding globulin and free thyroxine. J Clin Endocrinol Metab 29:957-961, 1969.

208.Beex L, Ross A, Smals P, Kloppenborg P: 5-Fluorouracil-induced increase of total thyroxine and triiodothyronine. Cancer Treat Rep 61:1291-1295, 1977.

209.Oltman JE, Friedman S: Protein-bound iodine in patients receiving perphenazine. JAMA 185:726-727, 1963.

210.Garnick MB, Larsen PR: Acute deficiency of thyroxine-binding globulin during L-asparaginase therapy. N Engl J Med 301:252-253, 1979.

210a.Cashin-Hemphill L, Spencer CA, Nocoloff JT, et al: Alterations in serum thyroid hormonal indices with colestipol-niacin therapy. Ann Intern Med 107:324-329, 1987.

210b.O'Brien T, Silverberg JD, Nguyen TT: Nicotinic-acid-induced toxicity associated with cytopenia and decreased levels of thyroxine-binding globulin. Mayo Clin Proc 67:465-468, 1992.

211.Stockigt JR, Lim CF, Barlow JW, et al: Interaction of furosemide with serum thyroxine-binding sites: In vivo and in vitro studies and comparison with other inhibitors. J Clin Endocrinol Metab 60:1025-1031, 1985.

212.Hollander CS, Scott RL, Burgess JA, et al: Free fatty acids: A possible regulator of free thyroid hormone levels in man. J Clin Endocrinol Metab 27:1219-1223, 1967.

213.Tabachnick M, Hao YL, Korcek L: Effect of oleate, diphenylhydantoin, and heparin on the binding of 125I-thyroxine to purified thyroxine-binding globulin. J Clin Endocrinol Metab 36:392-394, 1973.

214.Marshall JS, Tompkins LS: Effect of o,p'-DDD and similar compounds on thyroxine binding globulin. J Clin Endocrinol Metab 28:386-392, 1968.

215.Abiodun MO, Bird R, Havard CW, Sood NK: The effects of phenylbutazone on thyroid function. Acta Endocrinol 72:257-264, 1973.

216.Davis PJ, Hsu TH, Bianchine JR, Morgan JP: Effects of a new hypolipidemic agent, MK-185, on serum thyroxine-binding globulin (TBG) and dialysable fraction thyroxine. J Clin Endocrinol Metab 34:200-208, 1972.

217.Taylor R, Clark F, Griffiths ID, Weeke J: Prospective study of effect of fenclofenac on thyroid function tests. Br J Med 281:911-912, 1980.

218.Wiersinga WM, Fabius AJ, Touber JL: Orphenadrine, serum thyroxine and thyroid function. Acta Endocrinol 86:522-532, 1977.

219.Pages RA, Robbins J, Edelhoch H: Binding of thyroxine and thyroxine analogs to human serum prealbumin. Biochemistry 12:2773-2779, 1973.

220.Oppenheimer JH: Role of plasma proteins in the binding, distribution, and metabolism of the thyroid hormones. N Engl J Med 278:1153-1162, 1968.

221.Man EB, Reid WA, Hellegers AE, Jones WS: Thyroid function in human pregnancy. III. Serum thyroxine-binding prealbumin (TBPA) and thyroxine-binding globulin (TBG) of pregnant women aged 14 through 43 years. Am J Obstet Gynecol 103:338, 1969.

222.Glinoer D, Fernandez-Deville M, Ermans AM: Use of direct thyroxine-binding gloublin measurement in the evaluation of thyroid function. J Endocrinol Invest 1:329-335, 1978.

223.Braverman LE, Ingbar SH: Effects of norethandrolone on the transport in serum and peripheral turnover of thyroxine. J Clin Endocrinol Metab 27:389-396, 1967.

224.Graham RL, Gambrell RD: Changes in thyroid function tests during danazol therapy. Obstet Gyneocl 55:395-397, 1980.

224a.Draper MW, Flowers, DE, Neild JA, Huster WJ, Zerbe RL: Antiestrogenic properties of raloxifene. Pharmacology 50:209-17,1995

224b.Groonroos PE, Irjala KM, Selen GP, Forsstrom JJ: Computerized monitoring of potentially interfering medication in thyroid function diagnostics. Int j Clin Monit Comput 14:255-9,1997

224c.Amberson J, Drinka PJ: Medication and low serum thyroxine values in nursing home residents. South Med J 91:437-40,1998

225.Austen FK, Rubini ME, Meroney WH, Wolff J: Salicylates and thyroid function. I. Depression of thyroid function. J Clin Invest 37:1131-1143, 1958.

226.Wolff J, Austen FK: Salicylates and thyroid function. II. The effect on the thyroid-pituitary interrelation. J Clin Invest 37:1144-1165, 1958.

227.Christensen LK: Thyroxine-releasing effect of salicylate and of 2,4-dinitrophenol. Nature 183:1189-1190, 1959.

228.Larsen PR: Salicylate-induced increases in free triiodothyronine in human serum: Evidence of inhibition of triiodothyronine binding to thyroxine-binding globulin and thyroxine-binding prealbumin. J Clin Invest 51:1125-1134, 1972.

229.Oppenheimer JH, Tavernetti RR: Displacement of thyroxine from human thyroxine-binding globulin by analogues of hydantoin. Steric aspects of the thyroxine-binding site. J Clin Invest 41:2213-2220, 1962.

230.Schatz DL, Sheppard RH, Steiner G, et al: Influence of heparin on serum free thyroxine. J Clin Endocrinol Metab 29:1015-1022, 1969.

231.Hershman JM, Jones CM, Bailey AL: Reciprocal changes in serum thyrotropin and free thyroxine produced by heparin. J Clin Endocrinol Metab 34:574, 1972.

231a.Jaume JC, Mendel CM, Frost PH, Greenspan FS, Laughton CW: Extremely low doses of heparin release lipase activity into the plasms and can thereby cause artifactual elevations in the serum-free thyroxine concentration as measured by equilibrium dialysis. Thyroid 6;79-83,1996

231b.Stevenson HP, Archbold GP, Johnston P, Young IS, Sheridan B: Misleading serum free thyroxine results during low molecular weight heparin treatment. Clin Chem 44:1002-7,1998

232.Dowling JT, Frienkel N, Ingbar SH: The effect of estrogens upon the peripheral metabolism of thyroxine. J Clin Invest 39:1119-1130, 1974.

233.Refetoff S, Fang VS, Marshall JS, Robin NI: Metabolism of thyroxine-binding globulin (TBG) in man: Abnormal rate of synthesis in inherited TBG deficiency and excess. J Clin Invest 57:485-495, 1976.

234.Schlienger JL, Kapfer MT, Singer L, Stephan F: The action of clomipramine on thyroid function. Horm Metab Res 12:481-482, 1980.

235.Rootwelt K, Ganes T, Johannessen SI: Effect of carbamazapine, phenytoin and phenobarbitone on serum levels of thyroid hormones and thyrotropin in humans. Scand J Clin Lab Invest 38:731-736, 1978.

236.Northcutt RC, Stiel MN, Nollifield JW, Stant EG Jr.: The influence of cholestyramine on thyroxine absorption. JAMA 208:1857-1861, 1969.

237.Witztum JL, Jacobs LS, Schonfeld G: Thyroid hormone and thyrotropin levels in patients placed on colestipol hydrochloride. J Clin Endocrinol Metab 46:838-840, 1978.

238.Isley WL: Effect of rifampin therapy on thyroid function tests in a hypothyroid patient on replacement L-thyroxine. Ann Int Med 107:517-518, 1987.

238a.Campbell NR, Hasinoff BB, Stalts H, Rao B, Wong, NC: Ferrous sulfate reduces thyroxine efficacy in patietns with hypothyroidism. Ann Intern Med 117:1010-3,1992

238b.Liel Y, Sperber AD, Shany S: Nonspecific intestinal adsorption of levothyroxine by aluminum hydroxide. AM J Med 97:363-5,1994.

238c.Sherman SI, Tielens ET, Ladenson PW: Sucralfate causes malabsorption of L-thyroxine. Am J Med 96:531-5,1994.

239.Chopra IJ, Williams DE, Orgiazzi J, Solomon DH: Opposite effects of dexamethasone on serum concentrations of 3,3',5'-triiodothyronine (reverse T3) and 3,3',5-triiodothyronine (T3). J Clin Endocrinol Metab 41:911-920, 1975.

240.Duick DS, Warren DW, Nicoloff JT, et al: Effect of a single dose of dexamethasone on the concentration of serum triiodothyronine in man. J Clin Endocrinol Metab 39:1151-1154, 1974.

241.Burger A, Dinichert D, Nicod P, et al: Effects of amiodarone on serum triiodothyronine, reverse triiothyronine, thyroxine and thyrotropin. J Clin Invest 58:255-259, 1976.

242.Savoie JC, Massin JP, Thomopoulos P, Leger F: Iodine-induced thyrotoxicosis in apparently normal thyroid glands. J Clin Endocrinol Metab 41:685-691, 1975.

243.Lotti G, Delitala G, Devilla L, Alagna S, Masala A: Reduction of plasma triiodothyronine induced by propranolol. Clin Endocrinol 6:405, 1977.

244.Faber J, Kirkegaard C, Lumholtz IB, et al: Measurements of serum 3',5'-diiodothyronine and 3,3'-diiodothyronine concentrations in normal subjects and in patients with thyroid and nonthyroid disease: Studies of 3',5'-diiodothyronine metabolism. J Clin Endocrinol Metab 48:611-617, 1979.

245.Wiersinga WM, Touber JL: The influence of ß-adrenoreceptor blocking agents on plasma thyroxine and triiodothyronine. J Clin Endocrinol Metab 45:293-298, 1977.

246.Re RN, Kourides IA, Ridgway EC, et al: The effect of glucocorticoid administration on human pituitary secretion of thyrotropin and prolactin. J Clin Endocrinol Metab 43:338-346, 1976.

247.Larsen PR, Atkinson AJ, Wellman HN, Goldsmith RE: The effect of diphenylhydantoin on thyroxine metabolism in man. J Clin Invest 49:1266-,1279, 1970.

248.Schwartz HL, Kozyreff V, Surks MI, Oppenheimer JH: Increased deiodination of L-thyroxine and L-triiodothyronine by liver microsomes from rats treated with phenobarbital. Nature 221:1262-1263, 1969.

249.Schwartz HL, Bernstein G, Oppenheimer JH: Effect of phenobarbital administration on the subcellular distribution of 125I-thyroxine in rat liver: Importance of microsomal binding. Endocrinology 84:270, 1969.

250.Blum C, Corvette C, Beckers C: Effect of insulin induced hypoglycemia on thyroid function and thyroxine turnover. Eur J Clin Invest 3:124, 1973.

251.Johnstone RE, Kennel EM, Brummond W Jr., Shaw LM, Ebersole RC: Effect of halothane anesthesia on muscle, liver, thyroid, and adrenal-function tests in man. Clin Chem 22:217, 1976.

252.Scanlon MF, Weightman DR, Shale DJ, et al: Dopamine is a physiological regulator of thyrotropin (TSH) secretion in normal man. Clin Endocrinol 10:7-15, 1979.

253.Scanlon MF, Rodriguez-Arnao MD, Pourmand M, et al: Catecholaminergic interactions in the regulation of thyrotropin (TSH) secretion in man. J Endocrinol Invest 3:125-129, 1980.

254.Delitala G, Devilla L, Lotti G: Domperidone, an extracerebral inhibitor of dopamine receptors, stimulates thyrotropin and prolactin release in man. J Clin Endocrinol Metab 50:1127-1130, 1980.

255.Massara F, Camanni F, Belforte L, et al: Increased thyrotropin secretion induced by sulpiride in man. Clin Endocrinol 9:419-428, 1978.

256.Delitala G, Devilla L, Lotti G: TSH and prolactin stimulation by the decarboxylase inhibitor benserazide in primary hypothyroidism. Clin Endocrinol 12:313-316, 1980.

257.Kirkegaard C, Bjoerum CN, Cohn D, et al: Studies of the influence of biogenic amines and psychoactive drugs on the prognostic value of the TRH stimulation test in endogeneous depression. Psychoneuroendocrinology 2:131-136, 1977.

258.Kirkegaard C, Bjoerum N, Cohn D, Lauridsen UB: TRH stimulation test in manic-depressive illness. Arch Gen Psychiatry 35:1017-1021, 1978.

259.Nelis GF, Van DeMeene JG: The effect of oral cimetidine on the basal and stimulated values of prolactin, thyroid stimulating hormone, follicle stimulating hormone and luteinizing hormone. Postgrad Med J 56:26-29, 1980.

260.Feldt-Rasmussen U, Lange AP, Date J, Kern-Hansen M: Effect of clomifen on thyroid function in normal men. Acta Endocrinol 90:43-51, 1979.

261.Smals AG, Kloppenborg PW, Hoefnagesl WH, Drayer JM: Pituitary-thyroid function in spirolactone treated hypertensive women. Acta Endocrinol 90:577-584, 1979.

262.Morley JE, Shafer RB, Elson MK, et al: Amphetamine-induced hyperthyroxinemia. Ann Int Med 93:707-709, 1980.

263.Gloebel B, Weinheimer B: TRH-test during D-T4 application. Nuc-Compact 8:44, 1977.

264.Medeiros-Neto G, Kallas WG, Knobel M, et al: Triac (3,5,3'-triiodothyroacetic acid) partially inhibits the thyrotropin response to thyrotropin-releasing hormone in normal and thyroidectomized hypothyroid patients. J Clin Endocrinol Metab 50:223-225, 1980.

265.Emrich D: Untersuchungen zum einfluss von Etiroxat-HCL auf den Jodstoffwechsel beim menschen. Arzneim Forsch 27:422-426, 1977.

266.Tamagna EI, Hershman JM, Jorgensen EC: Thyrotropin suppression by 3,5-dimethyl-3'-isopropyl-L-thyronine in man. J Clin Endocrinol Metab 48:196-200, 1979.

267.Yoshimura M, Hachiya T, Ochi Y, et al: Suppression of elevated serum TSH levels in hypothyroidism by fusaric acid. J Clin Endocrinol Metab 45:95-98, 1977.

268.Delitala G, Rovasio P, Lotti G: Suppression of thyrotropin (TSH) and prolactin (PRL) release by pyridoxine in chronic primary hypothyroidism. J Clin Endocrinol Metab 45:1019-1022, 1977.

269.Masala A, Delitala G, Devilla L, et al: Effect of apomorphine and peribedil on the secretion of thyrotropin and prolactin in patients with primary hypothyroidism. Metabolism 27:1608-1612, 1978.

270.Delitala G, Wass JAH, Stubbs WA, et al: The effect of lisurgide hydrogen maleate, an ergot derivative on anterior pituitary hormone secretion in man. Clin Endocrinol 11:1-9, 1979.

271.Nilsson KO, Thorell JI, Hökfelt B: The effect of thyrotrophin releasing hormone on the release of thyrotrophin and other pituitary hormones in man under basal conditions and following adrenergic blocking agents. Acta Endocrinol 76:24-34, 1974.

272.Lamberg BA, Linnoila M, Fogelholm R, et al: The effect of psychotropic drugs on the SH-response to thyroliberin (TRH). Neuroendocrinology 24:90-97, 1977.

273.Delitala G, Rovasio PP, Masala A, et al: Metergoline inhibition of thyrotropin and prolactin secretion in primary hypothyroidism. Clin Endocrinol 8:69-73, 1978.

274.Ferrari C, Paracchi A, Rondena M, et al: Effect of two serotonin antagonists on prolactin and thyrotropin secretion in man. Clin Endocrinol 5:575-578, 1976.

275.Collu R: The effect of TRH on the release of TSH, PRL and GH in man under basal conditions and following methysergide. J Endocrinol Invest 2:121-124, 1978.

276.Yoshimura M, Ochi Y, Miyazaki T, et al : Effect of intravenous and oral administration of L-DOPA on HGH and TSH release. Endocrinol Jpn 19:543-548, 1972.

277.Porter BA, Refetoff S, Rosenfield RL, et al: Abnormal thyroxine metabolism in hyposomatotrophic dwarfism and inhibition of responsiveness to TRH during GH therapy. Pediatrics 51:668-674, 1973.

278.Siler TM, Yen SS, Guillemin R: Inhibition by somatostatin on the release of TSH induced in man by thyrotropin-releasing factor. J Clin Endocrinol Metab 38:742, 1974.

279.Weeke J, Hansen AP, Lundbaek K: Inhibition by somatostatin of basal levels of serum thyrotropin (TSH) in normal men. J Clin Endocrinol Metab 41:168-171, 1975.

279a.Colao A, Merola B, Ferone D, Marzullo P, Cerbone G, Longbardi S, Di Somma C, Lombardi G: Acute and chronic effects of octreotide on thyroid axis in growth hormone-secreting and clinically non-functional pituitary adenomas. Eur J Endocrinol 133:189-94,1995

280.Thomas JA, Shahid-Salles KS, Donovan MP: Effects of narcotics on the reproduction system. Avd Sex Horm Res 3:169-195, 1977.

281.May P, Mittler J, Manougian A, Erte N: TSH release-inhibiting activity of leucine-enkephaline. Horm Metab Res 11:30-33, 1979.

282.Chan V, Wang C, Yeung RT: Effects of heroin addiction on thyrotropin, thyroid hormones and prolactin secretion in men. Clin Endocrinol 10:557-565, 1979.

283.Kobayashi I, Shimomura Y, Maruta S, et al: Clofibrate and a related compound suppress TSH secretion in primary hypothyroidism. Acta Endocrinol 94:53-57, 1980.

284.Delitala G: Dopamine and TSH secretion in man. Lancet 2:760-761, 1977.

285.Refetoff S, Fang VS, Rapoport B, Friesen HG: Interrelationships in the regulation of TSH and prolactin secretion in man: Effects of L-DOPA, TRH and thyroid hormone in various combinations. J Clin Endocrinol Metab 38:450-457, 1974.

286.Miyai K, Onishi T, Hosokawa M, et al: Inhibition of thyrotropin and prolactin secretions in primary hypothyroidism by 2-Br--ergocryptine. J Clin Endocrinol Metab 39:391-394, 1974.

287.Burrow GN, May PB, Spaulding SW, Donabedian RK: TRH and dopamine interactions affecting pituitary hormone secretion. J Clin Endocrinol Metab 45:65, 1977.

288.Spaulding SW, Burrow GN, Donabedian RK, Van Woert M: L-dopa supression of thyrotropin releasing hormone response in man. J Clin Endocrinol Metab 35:182, 1977.

289.Collu R, Jéquier JC, Leboeuf G, et al: Endocrine effects of pimozide, a specific dopaminergic blocker. J Clin Endocrinol Metab 41:981-984, 1975.

290.Kleinman RE, Vagenakis AG, Braverman LE: The effect of iopanoic acid on the regulation of thyrotropin secretion in euthyroid subjects. J Clin Endocrinol Metab 51:399-403, 1980.

291.Faglia G, Ambrosi B, Beck-Peccoz P, et al: The effect of theophylline on plasma thyrotropin response (HTSH) to thyrotropin releasing factor (TRF) in man. J Clin Endocrinol Metab 34:906-909, 1972.

292.Wolff J, Varrone S: The methyll xanthines - A new class of goitrogens. Endocrinology 85:410-414, 1969.

293.Oyama T, Potsaid MS, Slingerland DW: Effect of diethyl ether anesthesia on thyroid function of rats: Pituitary, adrenal and thyroid relationship. Endocrinology 65:459, 1959.

294.Fore W, Kohler P, Wynn J: Rapid redistribution of serum thyroxine during ether anesthesia. J Clin Endocrinol Metab 26:821, 1966.

295.Cass R, Kuntzman R, Brodie BB: Norepinephrine depletion as possible mechanism of action of guanethidine (SU 5864), a new hypotensive drug. Proc Soc Exp Biol Med 103:871, 1960.

296.Gaffney TE, Braunwald E, Kahler RL: Effects of guanethidine on triiodothyronine induced hyperthyroidism in man. N Engl J Med 265:16-20, 1961.

297.Lee WY, Bronsky D, Waldstein SS: Studies of thyroid and sympathetic nervous system interrelationships. II. Effect of guanethidine on manifestations of hyperthyroidism. J Clin Endocrinol Metab 22:879-885, 1962.

298.Ramey ER, Bernstein H, Goldstein MS: Effect of sympathetic blocking agents on the increased oxygen consumption following administration of thyroxine. Fed Proc 14:118, 1955.

299.Surtskin A, Cordonnier JK, Lang S: Lack of influence of the sympathetic nervous system on the calorigenic response to thyroxine. Am J Physiol 188:503, 1957.

300.Schwartz NB, Hammond GE, Gronert GA: Interaction between thyroxine and dibenzyline on metabolic rate. Am J Physiol 191:573, 1957.

301.Cutting WC, Rytand DA, Tainter ML: Relationship between blood cholesterol and increased metabolism from dinitrophenol and thyroid. J Clin Invest 13:547-552, 1934.

301a.Anker GB, Lonning PE, Aakvaag A, Lien EA: Thyroid function in postmenopausal breast cancer patients treated with tamoxifen. Scand J Lab Clin Invest 58:103-7,1998.

301b.Hsu SH, Cheng WC, Jang MW, Tsai KS: Effects o long term use of raloxifene, a selective estrogen receptor modulator, on thyroid function test profiles. Clin Chem 47:1865-1867;2001

301c.Ceresini G, Morganti S, Rebecchi I, Bertone L, Ceda GP, Bacchi-Modena A, Sgarabotto M, Baldini M, Ablondi F, Valenti G, Braverman LE: A one-year follow-up on the effects of raloxifene on thyroid function in post-menopausal women. Menopause 11:176-9;2004

301dSiraj ES, Gupta MK, Reddy SS Raloxifene causing malabsorption of levothyroxine. Arch Intern Med 9:1367-70;2003

302.Ain KB, Mori Y, Refetoff S: Reduced clearance of thyroxine-binding globulin (TBG) with increased sialylation: A mechanism for estrogen induced elevation of serum TBG concentration. J Clin Endocrinol Metab 65:689-696, 1987.

303.Doe RP, Mellinger GT, Swaim WR, Seal JS: Estrogen dosage effects on serum proteins: A longitudinal study. J Clin Endocrinol Metab 27:1081-1086, 1967.

304.Ramey JN, Burrow GN, Polackwich RK, Donabedian RK: The effect of oral contraceptive steroids on the response of thyroid-stimulating hormone to thyrotropin-releasing hormone. J Clin Endocrinol Metab 40:712, 1975.

305.Gross HA, Appleman MD, Nicoloff JT: Effect of biologically active steroids on thyroid function in man. J Clin Endocrinol Metab 33:242-248, 1971.

306.Lemarchand-Beraud T, Rappoport G, Magrini G, Berthier C, Reymond M: Influences of different physiological conditions on the gonadotropins and thyrotropin responses to LHRH and TRH. Horm Metab Res 5 (suppl):170, 1974.

306a.Moreira RM, Lisboa PC, Curty FH, Pazos-Moura CC: Dose-dependent effects of 17-beta-estriol on pituitary thyrotropin content and secretion in vitro. Braz. J. Med. Biol. Res. 30:1129-34,1997.

306b.Zidan J, Rubenstein W: Effect of adjuvant tamoxifen therapy on thyroid function in postmenopausal women with breast cancer. Oncology 56:43-45, 1999.

307.Haigler ED Jr., Hershman JM, Pittman JA Jr., Blaugh CM: Direct evaluation of pituitary thyrotropin reserve utilizing thyrotropin releasing hormone. J Clin Endocrinol Metab 33:573-581, 1971.

308.Snyder PJ, Utiger RD: Response to thyrotropin releasing hormone (TRH) in normal man. J Clin Endocrinol Metab 34:380-385, 1972.

309.Carlson HE, Jacobs LS, Daughaday WH: Growth hormone, thyrothyropin and prolactin responses to thyrotropin-releasing hormone following diethylstilbestrol pretreatment. J Clin Endocrinol Metab 37:488, 1973.

310.Rutlin E, Haug E, Torjesen PA: Serum thyrotrophin, prolactin and growth hormone, response to TRH during oestrogen treatment. Acta Endocrinol 84:23-35, 1977.

311.Federman DD, Robbins J, Rall JE: Effects of methyl testosterone on thyroid function, thyroxine metabolism, and thyroxine-binding protein. J Clin Invest 37:1024, 1958.

312.Woeber KA, Barakat RM, Ingbar SH: Effects of salicylate and its noncalorigenic congeners on the thyroidal release of ¹³¹I in patients with thyrotoxicosis. J Clin Endocrinol Metab 224:1163-1168, 1964.

313.Dussault JH, Turcotte R, Guyda H: The effect of acetylsalicylic acid on TSH and PRL secretion after TRH stimulation in the human. J Clin Endocrinol Metab 43:232-235, 1976.

314.Langer P, Földes O, Michajlovskij N, et al: Short-term effect of acethylsalicylic acid on pituitary-thyroid axis and plasma cortisol level in healthy human volunteers. Acta Endocrinol 88:698, 1978.

315.Chopra IJ, Solomon DH, Chua Teco GN, Nguyen AH: Inhibition of hepatic outer ring monodeiodination of thyroxine and 3,3',5'-triiodothyronine by sodium salicylate. Endocrinology 106:1728-1734, 1980.

316.Alexander WD, Johnson KWM: A comparison of the effects of acetylsalicylic acid and DL-triiodothyronine in patients with myxoedema. Clin Sci 15:593-600, 1956.

317.Yamamoto T, Woeber KA, Ingbar SH: The influence of salicylate on serum TSH concentration in patients with primary hypothyroidism. J Clin Endocrinol Metab 34:423-426, 1972.

318.Woeber KA, Ingbar SH: The effects of noncalorigenic congeners of salicylate on the peripheral metabolism of thyroxine. J Clin Invest 43:931-942, 1964.

319.Christensen K: The metabolic effect of p-aminosalicylic acid. Acta Endocrinol 31:608-610, 1959.

320.MacGregor AG, Somner AR: The antithyroid action of para-amino salicylic acid. Lancet 2:931-936, 1954.

321.Christensen LK: The metabolic effect of salicylate and other hydroxybenzoates. Acta Pharmacol Toxicol 16:129, 1959.

322.McConnell RJ: Abnormal thyroid function in patients taking salsalate. JAMA 267:1242-1243, 1992.

323.Gamstedt A, Jarnerot A, Kagedal B, Soderholm B: Corticosteroids and thyroid function. Acta Med Scand 205:379, 1979.

324.Oppenheimer JH, Werner SC: Effect of prednisone on thyroxine-binding proteins. J Clin Endocrinol Metab 26:715-721, 1966.

325.Werner SC, Platman SR: Remission of hyperthyroidism (Graves' disease) and altered pattern of serum-thyroxine binding induced by prednisone. Lancet 2:751, 1965.

326.Otsuki M, Dakoda M, Baba S: Influence of glucocorticoids on TRF-induced TSH response in man. J Clin Endocrinol Metab 36:95, 1973.

327.Dussault JH: The effect of dexamethasone on TSH and prolactin secretion after TRH stimulation. Can Med Assoc J 111:1195-1197, 1974.

328.Berson SA, Yalow RS: The effect of cortisone on the iodine accumulating functions of the thyroid gland in euthyroid subjects. J Clin Endocrinol Metab 12:407, 1952.

329.Ingbar SH: The effect of cortisone on the thyroidal and renal metabolism of iodine. Endocrinology 53:171-181, 1953.

329a.Kaplan MM, Utiger RD: Iodothyronine metabolism in rat liver homogenates. J Clin Invest 61:459,1978.

329b.Samuels MH, McDaniel PA: Thyrotrophin levels during hydrocortisone infusions that mimic fasting-induced cortisol elevations: a clinical research study. J Clin Endocrinol Metab 82:3700-4,1997.

329c.Heikinheimo O, Ranta S, Grunberg S, Lahteenmaki P, Spitz IM: Alterations in pituitary-thyroid and pituitary-adrenal axes—consequences of long-term mifepristone treatment. Metabolism 46:292-6,1997.

330.Topliss DJ, White EL, Stockigt JR: Significance of thyrotropin excess in untreated primary adrenal insufficiency. J Clin Endocrinol Metab 50:52-56, 1980.

331.Tashjian AH, Osborne R, Maina D, Knaian A: Hydrocortisone increases the number of receptors for thyrotropin-releasing hormone on pituitary cells in culture. Biochem Biophys Res Commun 79:333, 1977.

331a.Bruhn TO, Huang SS, Vaslet C, Nillni EA: Glucocorticoids modulate the biosynthesis and processing of prothyrotropin releasing hormone (proTRH). Endocrine 9:143-52.1998.

331b.Jackson IM, Luo LG: Antidepressants inhibit the glucocorticoid stimulation of thyrotropin releasing hormone expression in cultured hypothalamic neurons. J Investig Med 46:470-4,1998.

332.Benoit FL, Greenspan FS: Corticoid therapy for pretibial myxedema. Observations on the long-acting thyroid stimulator. Ann Intern Med 66:711-720, 1967.

333.Yamada T, Ikejiri K, Kotani M, Kusakabe T: An increase of plasma triiodothyronine and thyroxine after administration of dexamethasone to hypothyroid patients with Hashimoto's thyroiditis. J Clin Endocrinol Metab 46:784-790, 1978.

334.Burgi H, Wimpfheimer C, Burger A, Zaunbauer W, Rosler H, Lamarchand-Beraud T: Changes of circulating thyroxine, triiodothyronine and reverse triiodothyronine after radiographic contrast agents. J Clin Endocrinol Metab 43:1203, 1976.

335.Wu SY, Chopra IJ, Solomon DH, Bennett LR: Changes in circulating iodothyronines in euthyroid and hyperthyroid subjects given Ipodate (Oragrafin), an agent for oral cholescystography. J Clin Endocrinol Metab 46:691-697, 1978.

336.Larsen PR, Dick TE, Markovitz BP, Kaplan MM, Gard TG: Inhibition of intrapituitary thyroxine to 3,5,3'-triiodothyronine conversion prevents the acute suppression of thyrotropin release by thyroxine in hypothyroid rats. J Clin Invest 64:117, 1979.

337.Felicetta JV, Green WL, Nelp WB: Inhibition of hepatic binding of thyroxine by cholecystographic agents. J Clin Invest 65:1032-1040, 1980.

338.DeGroot LJ, Rue PA: Roentgenographic contrast agents inhibit triiodothyronine binding to nuclear receptors in vitro. J Clin Endocrinol Metab 49:538-542, 1979.

338a.Brown RS, Cohen JH, Braverman LE: Successful treatment of massive acute thyroid hormone poisoning with iopanoic acid. J Pediatr 132:903-05,1998.

338b.Arem R, Munipalli B: Ipodate therapy in patients with severe destruction induces thyrotoxicosis. Arch Intern Med 156:1752-7,1996.

338c.Chopra IJ, van Herle AJ, Korenman SG, Viosca S, Younai S: Use of sodium ipodate in management of hyperthyroidism in subacute thyroiditis. J Clin Endocrinol Metab 80:2178-80,1995.

338d.Fontanilla JC, Schnedier AB, Sarne DH: The use of oral radiographic Contrast agents in the management of hyperthyroidism. Thyroid 11:561-567: 2001

339.Nademanee K, Piwonka RW, Singh BN, Hershman JM: Amiodarone and thyroid function. Prog Cardiovascul Dis 31:427-437, 1989.

339a.deJong M, Docter R, Van der Hoek H, et al: Different effects of amiodarone on transport of T4 and T3 into the perfused rat liver. Am J Physiol 266:E44, 1994.

339b.Vorperian VR, Havighurst TC, Miller S, January CT: Adverse effects of low dose amiodarone: a meta-analysis. J Am Coll Cardiol 30:791-8,1997.

339c.Hudig F, Bakker O, Wiersinga WM: Tri-iodothyronine prevent the amiodarone-induced decrease in the expression of the liver low-density lipoprotein receptor gene. J Endocrinol 152:413-21,1997

339d.Guo W, Kamiya K, Toyama J: Evidences of antagonism between amiodarone and triiodothyronine on the K+ channel activities of cultured rat cardiomyocytes. J Mol Cell Cardiol 29:617-27,1997.

340.Martino E, Safran M, Aghini-Lombardi F, et al: Environmental iodine intake and thyroid dysfunction during chronic amiodarone therapy. Ann Intern Med 101:28-34, 1984.

340a.Bartlena L, Brogioni S, Grasso L, Bogazzi F, Burelli A, Martino E: Treatment of amiodarone-induced thyrotoxicosis, a difficult challenge: results of a prospective study. J Clin Endocrinol Metab 81:2930-3,1996.

341.Schussler GC: Diazepam competes for thyroxine binding. J Pharmacol Exp Ther 178:204-209, 1971.

342.Molholm Hansen J, Skovsted L, Birk Lauridsen U, Kirkegaard C, Stersbaek-Nielsen K: The effect of diphenylhydantoin on thyroid function. J Clin Endocrinol Metab 39:785, 1974.

343.Heyma P, Larkins RG, Perry-Kenne D, Peter CT, Ross D, Sloman JG: Thyroid hormone levels and protein binding in patients on long term diphenylhydantoin treatment. Clin Endocrinol 6:369, 1977.

344.Cavalieri RR, Gavin LA, Wallace A, et al: Serum thyroxine, free T4, triiodothyronine, and reverse-T3 in diphenylhydantoin treated patients. Metabolism 28:1161-1165, 1979.

344a.Surks MI, DeFesi CR: Normal serum free thyroid hormone concentrations in patients treated with phenytoin or carbamazapine, a paradox resolved. JAMA 275:1495-8,1996

344b.Tiihonen M, Liewendahl K, Waltimo O, Ojala M, Valimaki M: Thyroid status of patients receiving long-term anticonvulsant therapy assessed by peripheral parameters: a placebo-controlled thyroxine therapy trial. Epilepsia 36:1118-25,1995

345.Hansen JM, Skovsted L, Lauridsen UB, Kirkegaard C, Siersbaek-Nielsen K: The effect of diphenylhydantoin on thyroid function. J Clin Endocrinol Metab 39:785-, 1974.

346.Blackshear JL, Schultz AL, Napier JS, Stuart DD: Thyroxine replacement requirements in hypothyroid patients receiving phenytoin. Ann Intern Med 99:341-359, 1983.

347.Oppenheimer JH, Shapiro HC, Schwartz HL, Surks MI: Dissociation between thyroxine metabolism and hormonal action in phenobarbital-treated rats. Endocrinology 88:115, 1971.

347a.Brookstaff RC, Murphy VA, Skare JA, Minnema D, Sangiri U, Parkinson A: Effects of doxylamine succinate on thyroid hormone balance and enzyme induction in mice. Toxicol Appl Pharmacol 141:584-94,1996.

348.Cavalieri RR, Sung LC, Becker CE: Effects of phenobarbital on thyroxine and triiodothyronine kinetics in Graves' disease. J Clin Endocrinol Metab 37:308-316:1973.

348a.Rootwelt K, Ganes T, Johannessen SI: Effects of carbamazapine, phenytoin and phenobarbitone on serum levels of thyroid hormones and thyrotropin in humans. Scan J Clin Lab Invest 38:731,1978.

349.Wartofsky L, Dimond RC, Noel GL, et al: Failure of propranolol to alter thyroid iodine release, thyroxine turnover, or the TSH and PRL responses to thyrotropin-releasing hormone in patients with thyrotoxicosis. J Clin Endocrinol Metab 41:485-490, 1975.

350.Woolf PD, Lee LA, Schalch DS: Adrenergic manipulation and thyrotropin releasing hormone (TRH)-induced thyrotropin (TSH) release. J Clin Endocrinol Metab 35:616-, 1972.

351.Faber J, Friis T, Kirkegaard C, et al: Serum T4, T3, and reverse T3 during treatment with propranolol in hyperthyroidism, L-T4 treated myxedema and normal man. Horm Metab Res 11:34-36, 1979.

352.Faber J, Kirkegaard C, Lumholtz IB, Siersbaek-Nielsen K, Friis T: Variations in serum T3, rT3, 3,3'-diiodothyronine and 3',5'-diiodothyronine induced by acute myocardial infarction and propranolol. Acta Endocrinol 94:341, 1980.

353.Murchison LE, How J, Bewsher PD: Comparison of propranolol and metoprolol in the management of hyperthyroidism. Br J Clin Pharmacol 8:581, 1979.

354.How ASM, Khir AN, Bewsher PD: The effect of atenolol on serum thyroid hormones in hyperthyroid patients. Clin Endocrinol 13:299-302, 1980.

355.Hadden DR, Bell TK, McDevitt DG, Shanks RG, Montgomery DAD, Weaver JA: Propranolol and the utilization of radioiodine by the human thyroid gland. Acta Endocrinol 61:393, 1969.

356.Wilson WR, Theilen ED, Fletcher FW: Propranolol and its effects in thyrotoxicosis on heart at rest or exercise. J Clin Invest 43:1697, 1964.

357.Das G, Krieger M: Treatment of thyrotoxic storm with intravenous administration of propranolol. Ann Intern Med 70:985, 1969.

358.Canary JJ, Shaaf M, Duffy BJ Jr., Kyle LH: Effects of oral and intramuscular administration of reserpine in thyrotoxicosis. N Engl J Med 257:435, 1957.

359.Waud DR, Kattegoda SR, Krayer O: Threshold dose and time course of norepinephrine depletion of mammalian heart by reserpine. J Pharmacol Exp Ther 124:340, 1958.

360.Goldberg RC, Wolff J, Greep RO: Studies on the nature of the thyroid-pituitary interrelationship. Endocrinology 60:38, 1957.

361.Goldberg RC, Wolff J, Greep RO: The mechanism of depression of plasma protein-bound iodine by 2,4-dinitrophenol. Endocrinology 56:560-566, 1955.

362.Lardy HA, Wellman H: Oxidative phosphorylations: Role of inorganic phosphate and acceptor systems in control of metabolic rates. J Biol Chem 195:215-224, 1952.

363.Escobar del Rey F, Morreale de Escobar G: Studies on the peripheral disappearance of thyroid hormone. IV. The effect of 2,4-dinitrophenol on the ¹³¹I distribution in thyroidectomized, L-thyroxine maintained rats, 24 hours after the injection of ¹³¹I-labeled L-thyroxine. Acta Endocrinol 29:161-175, 1958.

364.Escobar del Rey F, Morreale de Escobar G: Studies on the peripheral disappearance of thyroid hormone. V. The effect of 2,4-dinitrophenol on the variations of the ¹³¹I distribution pattern with time, after the injection of ¹³¹I-labeled L-thyroxine into thyroidectomized, L-thyroxine maintained rats. Acta Endocrinol 29:176, 1958.

365.Cutting CC, Tainter ML: Comparative effects of dinitrophenol and thyroxin on tadpole metamorphosis. Proc Soc Exp Biol Med 31:97-100, 1933.

366.Reichlin S: Regulation of the hypophysiotropin secretion of the brain. Arch Intern Med 135:1350, 1975.

367.Morley JE: Neuroendocrine control of thyrotropin secretion. Endocr Rev 2:396-436, 1981.

368.Kaptein EM, Spencer CA, Kamiel MB, Nicoloff JT: Prolonged dopamine administration and thyroid hormone economy in normal and critically ill subjects. J Clin Endocrinol Metab 51:387-393, 1980.

368a.deZegher F, Van den Bershe G, Dumoulin M, Gewillig M, Daenen W, Deviliger H: Dopamine suppresses thyroid-stimulating hormone secretion in neonatal hypothyroidism. Acta Paediatr 84:213-4,1995

368b.Martignoni E, Horowski R, Liuzzi A, Costa A, Dallabonzana D, Cozzi R, Attanasio R, Rainer E, Nappi G. Clin Neuropharmacol 19:72-80, 1996

368c.Samuels MH, Kramer P: Effects of metoclopramide on fasting-induced TSH suppression. Thyroid 6:85-9,1996

369.Benker G, Zäh W, Hackenberg K, Hamburger B, Gunnewig H, Reinwein D: Long-term treatment of acromegaly with bromocryptine: Postprandial HGH levels and response to TRH and glucose administration. Horm Metab Res 8:291, 1976.

370.Köbberling J, Darrach A, Del Pozo E: Chronic dopamine receptor stimulation using bromocryptine: Failure to modify thyroid function. Clin Endocrinol 11:367-370, 1979.

371.Foord SM, Peters J, Scanlon MF, Rees-Smith B, Hall R: Dopaminergic control of TSH secretion in isolated pituitary cells. FEBS Lett 121:257, 1980.

372.Heinen E, Herrmann J, Konigshausen T, Kruskemper HL: Secondary hypothyroidism in severe non-thyroidal illness? Horm Metab Res 13:284-288, 1981.

373.Weintraub BD, Gershengorn MC, Kourides IA, Fein H: Inappropriate secretion of thyroid stimulating hormone. Ann Intern Med 95:339-351, 1981.

Chanson P, Weintraub BD, Harris AG: Octreotide therapy for thyroid hormone-stimulating hormone-secreting pituitary adenomas. Ann Int Med 119:236-240, 1994.

Fernandez-Soto L, Gonzalez A, Escobar_jimenez F, Vazquez R, Ocete E, Olea N, Salmeron J: Increased risk of autoimmune thyroid disease in hepatitis C vs hepatitis B before, during and after discontinuing interferon therapy. Arch Intern Med 158:1445-8, 1998.

Amenomori M, Mori T, Fukuda Y, Sugawa H, Nishida N, Furukawa M, Kita R, Sando T, Komeda T, Nakao K: Incidence and characteristics of thyroid dysfunction following interferon therapy in patients with chronic hepatitis C. Intern Med 37:246-52, 1998.

Koh LK, Greenspan FS, Yeo PP: Interferon-alpha induced thyroid dysfunction: three clinical presentations and a review of the literature. Thyroid 7:891-6,1997.

Schuppert F, Rambusch E, Kirchner H, Atzpodien J, Kohn LD, von zur Muhllen A: Patients treated with interferon-alpha, interferon-beta, and interleukin-2 have a different autoantibody pattern than patients suffering from endogenous thyroid disease. Thyroid 7:837-42,1997.

Krouse RS, Yoral RE, Heywood G, Weintraub BD, White DE, Steinberg SM, Rosenberg SA, Schwartzentruber DJ: Thyroid dysfunction in 281 patients with metastatic melanoma or renal carcinoma treated with interleukin-2 alone. J Immunother Emphasis Tumor Immunol 18:272-8,1995.

379a.Prummel MF, Laurberg P: Interferon- and autoimmuine thyroid disease. Thyroid 13:547-551, 2003

Corssmit EP, Heyligenberg R, Endert E, Sauerwein HP, Romijn JA: Acute effects of interferon-alpha on thyroid hormone metabolism in healthy men. J Clin Endocrinol Metab 80:3140-4, 1995.

Witske O, Winterhagen T, Saller, B, Rogenbuck U, Lehr I, Phillipp T, Mann K, Reinhardt W: Transient stimulatory effect on pituitary-thyroid axis in patients treated with interleukin-2 Thyroid 11:665-670, 2001

Desai J, Yassa L, Marqusee E, George S, Frates MC, Chen MH, Morgan JA, Dychter SS, Larsen PR, Demetri GD, Alexander EK: Hypothyroidism after suntinib treatment for patients with gastrointestinal stromal tumors. Ann Intern Med 145:660-4, 2006

Wong E, Rosen LS, Mulay M, Vanvugt A, Dinolfo M, Tomoda C, Sugawara M, Hershman JM: Sunitinib induces hypothyroidism in advanced cancer patients and may inhibit thyroid peroxidase activity. Thyroid 17:351-5,2007

DeGroot JW, Zonnenberg BA, Plukker JT, van DerGraaf WT, Links TP: Imatinib induces hypothyroidism in patients receiving levothyroxine. Clin Phamacol Ther 78:4334-8, 2005

Sherman SI, Gopal J, Haugen BR, Chiu AC, Whaley K, Nowlakha P, Duvic M: Central hypothyroidism associated with retinoid X receptor selective ligands. N Engl J Med 340:1075-9, 1999

Golden WM, Weber KB, Hernandez TL, Sherman SI, Woodmansee WW, Haugen BR: Single-dose rexinoid rapidly and specifically suppresses serum thryotropin in normal subjects. J Clin Endocrinol Metab 92:124-30, 2007

Smit JWA, Stokkel MPM, Pereira AM, Romijn JA, Visser TJ: Bexarotene-induced hypothyroidism: Bexarotene stimulates the peripheral metabolism of thyroid hormones. J Clin Endocrinol Metab 92:2496-99, 2007

Vigersky RA, Filmore-Nassar A, Glass AR: Thyrotropin suppression by metformin. J Clin Endocrinol Metab 91:225-7, 2006